102 related articles for article (PubMed ID: 2268558)
1. Synthesis of 4,19-disubstituted derivatives of DOC. Radioreceptor assay of some corticosteroid derivatives in human mononuclear leukocytes.
Harnik M; Kashman Y; Cojocaru M; Bauer H; Laux M; Lewicka S; Vecsei P
J Steroid Biochem Mol Biol; 1990 Oct; 37(2):261-7. PubMed ID: 2268558
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of the 6 alpha- and 6 beta-hydroxylated derivatives of corticosterone, 11-dehydrocorticosterone, and 11-deoxycortisol.
Kraan GP; van Wee KT; Wolthers BG; van der Molen JC; Nagel GT; Drayer NM; van Leusen D
Steroids; 1993 Oct; 58(10):495-503. PubMed ID: 8256261
[TBL] [Abstract][Full Text] [Related]
3. 18-substituted steroids--9[1]. Studies on the stability of aldosterone in dilute alkali.
Kirk DN; Miller BW
J Steroid Biochem; 1982 Feb; 16(2):269-76. PubMed ID: 7078164
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 18-hydroxy-19-norcorticosterone and 18-deoxy-19-noraldosterone. Structure determination of related 19-nor steroids by means of 2-D 1H nmr.
Harnik M; Kashman Y; Carmely S; Cojocaru M; Dale SL; Holbrook MM; Melby JC
Steroids; 1986 Jan; 47(1):67-81. PubMed ID: 3810700
[TBL] [Abstract][Full Text] [Related]
5. High affinity aldosterone binding to plasma membrane rich fractions from mononuclear leukocytes: is there a membrane receptor for mineralocorticoids?
Wehling M; Christ M; Theisen K
Biochem Biophys Res Commun; 1991 Dec; 181(3):1306-12. PubMed ID: 1662496
[TBL] [Abstract][Full Text] [Related]
6. Microbial transformations of hypolipemic E-guggulsterone.
Atta-ur-Rahman ; Choudhary MI; Shaheen F; Ashraf M; Jahan S
J Nat Prod; 1998 Apr; 61(4):428-31. PubMed ID: 9584395
[TBL] [Abstract][Full Text] [Related]
7. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 3 beta,16 beta,19-trihydroxyandrost-5-en-17-one and 16 beta,19-dihydroxyandrost-4-ene-3,17-dione and their 19-oxo derivatives.
Numazawa M; Mutsumi A; Hoshi K; Ishimura S; Shoji S; Sekihara H
Steroids; 1990 Sep; 55(9):383-9. PubMed ID: 2281514
[TBL] [Abstract][Full Text] [Related]
9. Preparation of 3 beta, 5 alpha-, 3 alpha, 5 alpha- and 3 alpha, 5 beta-tetrahydro derivatives of 19-noraldosterone by chemical synthesis and microbial bioconversion.
Harnik M; Kashman Y; Carmely S; Cojocaru M
J Steroid Biochem; 1988 Jul; 31(1):97-105. PubMed ID: 3398535
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of 21-hydroxypregn-4-ene-3,20-dione (deoxycorticosterone) derivative compounds. Part I: Synthesis and circular dichroism identification.
Kouadio L; Bernard P; Sabot JF; Petit-Ramel MM; Barbier CM; Pinatel HJ
Steroids; 1988; 51(3-4):349-61. PubMed ID: 3217959
[TBL] [Abstract][Full Text] [Related]
11. The scope and limitations of the reaction of delta 5-steroids with mercury(II) trifluoroacetate.
Ruddock PL; Williams DJ; Reese PB
Steroids; 1998 Dec; 63(12):650-64. PubMed ID: 9870262
[TBL] [Abstract][Full Text] [Related]
12. 19-nor analogs of adrenal steroids: mineralocorticoid and glucocorticoid receptor activity.
Wynne KN; Mercer J; Stockigt JR; Funder JW
Endocrinology; 1980 Nov; 107(5):1278-80. PubMed ID: 6253261
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 19-hydroxyaldosterone and the 3 beta-hydroxy-5-ene analog of aldosterone, active mineralocorticoids.
Harnik M; Kashman Y; Aharonowitz Y; Morris DJ
J Steroid Biochem; 1985 Aug; 23(2):207-18. PubMed ID: 4033120
[TBL] [Abstract][Full Text] [Related]
14. An improved synthesis of 18-norandrost-4-ene-3,17-dione.
Davioud E; Schambel P; Viger A; Marquet A
Steroids; 1993 Mar; 58(3):141-4. PubMed ID: 8475519
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new 11 beta-substituted spirolactone derivatives. Relationship with affinity for mineralocorticoid and glucocorticoid receptors.
Claire M; Faraj H; Grassy G; Aumelas A; Rondot A; Auzou G
J Med Chem; 1993 Aug; 36(16):2404-7. PubMed ID: 8360885
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 19-noraldosterone, a potent mineralocorticoid.
Harnik M; Kashman Y; Cojocaru M; Rosenthal T; Morris DJ
J Steroid Biochem; 1986 Jun; 24(6):1163-9. PubMed ID: 3736043
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
Numazawa M; Kamiyama T; Tachibana M; Oshibe M
J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 19-oxygenated derivatives of the competitive inhibitor of aromatase, 5-androstene-4,17-dione.
Numazawa M; Yamada K
Steroids; 1999 May; 64(5):320-7. PubMed ID: 10406481
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the 21-yl sulfates of 11-beta, 17-alpha,21-trihydroxypregn-4-ene-3,20-dione; 17-alpha,21-dihydroxypregn-4-ene-3, 11,20-trione; 11-beta,21-dihydroxyregn-4-ene-3,20-dione; 21-hydroxypregn-4-ene-3, 11,20-trione and 21-hydroxypregn-4-ene,3,20-dione in human cord plasma.
Branchaud C; Schweitzer M; Giroud CJ
Steroids; 1969 Aug; 14(2):179-90. PubMed ID: 5822948
[No Abstract] [Full Text] [Related]
20. Synthesis of 18-substituted steroids. Part I. 18,21-Dihydroxypregn-4-ene-3,20-dione (18-hydroxydeoxycorticosterone).
Kirk DN; Rajagopalan MS
J Chem Soc Perkin 1; 1975; (19):1860-4. PubMed ID: 1238412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
